Towards a systematic nationwide screening strategy for MODY Beverley ShieldsKevin Colclough Commentary 29 January 2017 Pages: 609 - 612
Emerging role of intestinal microbiota and microbial metabolites in metabolic control Hilde HerremaRichard G. IJzermanMax Nieuwdorp Commentary 24 December 2016 Pages: 613 - 617
Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes Graham R. LawMark S. GilthorpeEleanor M. Scott Article Open access 19 January 2017 Pages: 618 - 624
Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry Bente B. JohanssonHenrik U. IrgensPål R. Njølstad Article 02 December 2016 Pages: 625 - 635
Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 Cécile BillionnetDelphine MitanchezSophie Jacqueminet Article Open access 15 February 2017 Pages: 636 - 644
Differential methylation of genes in individuals exposed to maternal diabetes in utero Peng ChenPaolo PiaggiRobert L. Hanson Article 26 January 2017 Pages: 645 - 655
Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes Laura MarroquiReinaldo S. Dos SantosDecio L. Eizirik Article 06 January 2017 Pages: 656 - 667
Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes Ting YuanSahar RafizadehAmin Ardestani Article 21 December 2016 Pages: 668 - 678
Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice Jeanette E. VillanuevaStacey N. WaltersShane T. Grey Article 06 January 2017 Pages: 679 - 689
Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice Vincent Blasco-BaqueBerengère CoupéMatteo Serino Article Open access 19 January 2017 Pages: 690 - 700
Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels Joshua R. WillardBreanne M. BarrowSakeneh Zraika Article 08 December 2016 Pages: 701 - 708
Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile Adam D. FarmerAnne Grave PedersenChristina Brock Original article 20 January 2017 Pages: 709 - 718
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy Sara RezzolaMichela CorsiniMarco Presta Article 13 January 2017 Pages: 719 - 728
AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin Emma BörgesonVille WalleniusKumar Sharma Article Open access 10 February 2017 Pages: 729 - 739
Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes Mohammed AbdelsaidMaha CouchaAdviye Ergul Article 23 January 2017 Pages: 740 - 750
PCSK9 inhibition and the global diabetes epidemic Luca MascitelliMark R. Goldstein Letter 29 January 2017 Pages: 751 - 752
Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Martha L. Campbell-ThompsonMark A. AtkinsonPeter A. In’t Veld Letter 09 January 2017 Pages: 753 - 755
Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Reply to Campbell-Thompson ML, Atkinson MA, Butler AE et al [letter] Marcus LundbergPeter SeironOskar Skog Letter 22 January 2017 Pages: 756 - 757
Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes Emily J. GallagherZara ZelenkoDerek LeRoith Erratum 23 February 2017 Pages: 758 - 759
